Healthcare / Medical Care FacilitiesKOSDAQ
$4505.00
-115.00 (-2.49%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $5.6B · quality 66.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
64/100
B
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$107.2B
P/E
15.1x
↓EV/EBITDA
7.3x
↓ROE
9.3%
↑Gross Margin
29.1%
↓Debt/Equity
0.22
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+19.7%
FCF CAGR
+16.6%
FCF margin
20.1%
FCF / Net income
1.88x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $66.63B · net income $7.13B · FCF $13.40B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $66.63B | $66.63B | $58.65B | $47.84B | $38.87B |
| Net Income | $7.13B | $7.13B | $5.28B | $3.74B | $4.41B |
| EBITDA | $14.03B | $14.03B | $8.85B | $6.75B | $7.12B |
| EPS | 298.00 | 298.00 | 221.00 | 157.00 | 48.50 |
| Gross Margin | 29.1% | 29.1% | 30.5% | 27.0% | 35.7% |
| Operating Margin | 7.9% | 7.9% | 8.6% | 3.3% | 15.0% |
| Net Margin | 10.7% | 10.7% | 9.0% | 7.8% | 11.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.22 | 0.22 | 0.06 | 0.08 | 0.11 |
| Current Ratio | 3.65 | 3.65 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $13.40B | $13.40B | $-1.58B | $5.65B | $8.46B |
| Returns | |||||
| ROE | 9.3% | 9.3% | 7.8% | 6.8% | 9.0% |
| Valuation | |||||
| P/E | 15.12 | 15.12 | 13.62 | 20.29 | 60.31 |
| EV/EBITDA | 7.28 | 7.28 | 5.99 | 10.84 | 8.85 |
| P/B | 1.41 | 1.41 | 1.06 | 1.36 | 1.36 |
| Growth & Yield | |||||
| Revenue Growth | 13.6% | 13.6% | 22.6% | 23.1% | — |
| EPS Growth | 34.8% | 34.8% | 40.8% | 223.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
10.3%
EPS terminal req.
$399.74
Spread vs growth
24.6%
5Y implied EPS CAGR
10.2%
EPS terminal req.
$483.69
Spread vs growth
24.7%
10Y implied EPS CAGR
10.1%
EPS terminal req.
$778.99
Spread vs growth
24.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+50.2%
Start / end P/E
13.6x → 15.1x
EPS bridge
221.00 → 298.00
Residual
+4.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.